Can Technology Make Pathology More Human? Part 2 - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Can Technology Make Pathology More Human? Part 2

  • By

  • Helen Bristow

  • September 4, 2026

  • 9 min

Share

Can Technology Make Pathology More Human? Part 2

Overview

The discussion highlights the role of AI in enhancing pathology practices, emphasizing that AI tools are designed to support pathologists rather than replace them.

Background

As the demand for pathology services rises, the integration of AI technologies is becoming crucial. These tools aim to streamline workflows and enhance diagnostic capabilities.

Data Highlights

No numerical or trial data presented in the article.

Key Findings

  • AI is viewed as a tool to enhance the pathologist's work, not to diminish their autonomy.
  • Pathologists may evolve into treatment specialists, guiding therapeutic decisions alongside oncologists.
  • AI can help manage increasing demands on pathology services.
  • Lessons from radiology suggest that efficiency gains from AI must translate into new value creation for pathologists.
  • AI's role includes automating routine tasks.

Clinical Implications

The integration of AI in pathology could lead to improved diagnostic efficiency.

Conclusion

AI presents opportunities for the pathology profession, enabling pathologists to focus on complex decision-making.

Related Resources & Content

  1. the pathologist, The Pathologist, 2026 -- Can Technology Make Pathology More Human? Part 1
  2. the pathologist, The Pathologist, 2026 -- The Pathology of Pathology
  3. the pathologist, The Pathologist, 2023 -- It’s a People Thing
  4. Guidance for laboratory implementation, governance and continuous assurance of artificial intelligence in histopathology | Virchows Archiv | Springer Nature, 2026 -- Guidance for laboratory implementation
  5. FDA, 2025 -- FDA Qualifies First AI Drug Development Tool, Will Be Used in 'MASH' Clinical Trials
  6. the pathologist — The Promise Of Computational Pathology: Part 2
  7. Guidance for laboratory implementation, governance and continuous assurance of artificial intelligence in histopathology | Virchows Archiv | Springer Nature Link
  8. FDA Qualifies First AI Drug Development Tool, Will Be Used in 'MASH' Clinical Trials | FDA
  9. Deep learning-assisted versus manual reading in routine cervical cytopathology: a multicentre randomised crossover trial | npj Digital Medicine

Original Source(s)

Related Content